Table 2.
Isobolographic analysis of interactions between CBD and CDDP (at the fixed ratio of 1:1) in melanoma malignant cell lines.
| Cell Line | IC50 mix
(μg/mL) |
n mix | Lower IC50 add (μg/mL) | n add | Upper IC50 add (μg/mL) | Interaction |
|---|---|---|---|---|---|---|
| SK-MEL 28 | 7.95 ± 0.31 * | 96 | 2.56 ± 0.78 | 158 | 6.15 ± 0.84 | Antagonism |
| A375 | 10.92 ± 1.33 ** | 96 | 0.98 ± 0.44 | 356 | 6.90 ± 0.63 | Antagonism |
| FM55P | 4.40 ± 0.43 * | 72 | 1.51 ± 0.48 | 140 | 2.85 ± 0.61 | Antagonism |
| FM55M2 | 5.53 ± 0.41 | 96 | 1.84 ± 0.59 | 132 | 5.29 ± 0.66 | Additivity |
The IC50 values (in µg/mL ± S.E.M.) for the mixture of CBD with CDDP were determined experimentally (IC50 mix) in four melanoma malignant cell lines in the in vitro MTT assay. The IC50 add values were calculated from the lower and upper isoboles of additivity. The n mix—total number of items experimentally determined; n add—total number of items calculated for the additive mixture of CBD with CDDP; * p < 0.05 and ** p < 0.01 vs. the respective IC50 add value.